Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Ophthalmology

Understanding Trachoma

At a Glance

Trachoma begins as a childhood eye infection that can return repeatedly. Over time, repeated swelling scars the eyelid, turns eyelashes inward, and makes them scratch the eye; without treatment, this can cause permanent vision loss. Face washing, antibiotics, sanitation, and surgery can help prevent blindness.

Trachoma is the world’s leading infectious cause of blindness [1]. Rather than simply being a “disease of poverty,” it is a condition closely associated with structural challenges: inadequate access to clean water, limited sanitation, crowded housing, and barriers to healthcare [2]. While the infection begins in childhood, its most serious consequences—such as vision loss—usually appear years or even decades later in adulthood [3].

By understanding how the infection spreads and how it progresses, you can take steps to protect your sight and the health of your family.

The Cause: A Silent Cycle of Infection

Trachoma is caused by a bacterium (a type of germ) called Chlamydia trachomatis [1]. Unlike the types of Chlamydia that affect other parts of the body, these specific strains target the eyes [2].

The infection spreads through contact with infected secretions (fluid) from the eyes or nose [2]. This can happen through:

  • Direct contact: Touching an infected person’s face and then touching your own eyes.
  • Shared items: Using the same towels or washcloths as someone with the infection [4].
  • Flies: Certain types of flies are attracted to eye and nose discharge and can carry the bacteria from one person to another [2].

In communities where trachoma is common, children are the main “reservoir” of the bacteria because they often play closely together and may have more frequent eye discharge [4][2].

Why Caregivers Face Higher Risks

Trachoma does not affect everyone equally. Women are significantly more likely than men to suffer from the advanced, blinding stages of the disease [5][6].

This higher burden is multifactorial. Because women often spend the most time caring for young children—who frequently have active infections—they are repeatedly exposed to the bacteria [1]. Over a lifetime, these repeated infections lead to more severe scarring [5]. Inequalities in access to surgical treatment can also leave women suffering from advanced stages longer than men. However, men, boys, and any person acting as a primary caregiver can also be affected.

The Long Timeline to Vision Loss

Trachoma is a “slow-motion” disease. It moves through two distinct phases over many years:

  1. Childhood (Active Phase): Children often have “active trachoma,” where the eyes are red, irritated, or bumpy on the inside of the eyelid [1]. While uncomfortable, this stage does not usually cause immediate vision loss. However, each new infection triggers inflammation (the body’s swelling response), which sets the stage for future damage [7].
  2. Adulthood (Scarring Phase): After years of repeated infections, the inside of the eyelid begins to develop scarring [8]. As the scars tighten, they pull the eyelid inward. Eventually, the eyelashes turn in and begin to rub against the cornea (the clear front window of the eye) [8]. This painful condition is called trichiasis. If not corrected with surgery, the constant scratching creates a dense opacity (cloudiness) on the cornea, leading to permanent blindness [8].

Because scarring can continue even after the bacteria are gone, people who had many infections as children may still develop vision problems as older adults, even if the community is now healthier [9].

The SAFE Strategy: A Path to Prevention

The World Health Organization (WHO) uses a four-part plan called the SAFE strategy to combat trachoma [10]. This strategy addresses both the immediate need for treatment and the long-term need for prevention.

  • S - Surgery: For people whose eyelashes have already turned inward, a simple eyelid surgery can stop the scratching and prevent further vision loss [10].
  • A - Antibiotics: Health programs provide a single dose of an antibiotic to the entire eligible community once a year to kill the bacteria [11].
  • F - Facial Cleanliness: Encouraging everyone to wash their faces with clean water helps prevent the bacteria from spreading and discourages flies [12].
  • E - Environmental Improvement: Increasing access to clean water and better sanitation (like latrines) reduces the presence of flies and makes it easier for families to maintain hygiene [12][13].

Common questions in this guide

What causes trachoma, and how is it spread?
Trachoma is caused by eye-infecting strains of the bacterium Chlamydia trachomatis. It can spread through infected eye or nose fluid, direct contact, shared towels or washcloths, and certain flies.
Can a childhood trachoma infection cause blindness as an adult?
Yes. Repeated infections can inflame and scar the inside of the eyelid, causing the eyelashes to turn inward and scratch the clear front of the eye. Without treatment, this damage can cause permanent vision loss, and scarring may continue even after the bacteria are gone.
Why are women and caregivers at greater risk from trachoma?
Women and other primary caregivers may have more repeated contact with young children who have active infections. Over time, repeated exposure can increase scarring, while limited access to eyelid surgery can allow advanced disease to last longer; men and boys can also be affected.
What does the WHO SAFE strategy do for trachoma?
SAFE combines eyelid surgery for inward-turning eyelashes, antibiotics to kill the bacteria, face washing with clean water, and improvements in water and sanitation. Together, these measures treat existing problems and reduce the spread that causes future scarring.
What signs of trachoma should prompt an eye evaluation?
Seek an eye evaluation if eyelashes turn inward or feel as though they are scratching the eye, especially with pain, persistent discharge, corneal cloudiness, or vision changes. Early treatment of inward-turning eyelashes can help prevent further damage.
Can antibiotics reverse trachoma-related eyelid scarring?
Antibiotics can kill the bacteria and help control infection, but they do not reverse established eyelid scarring or eyelashes that have turned inward. Surgery may be needed to stop the eyelashes from scratching the eye and to protect vision.

Get notified when new evidence is published on trachoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Trachoma.

    Habtamu E, Harding-Esch EM, Greenland K, et al.

    Lancet (London, England) 2025; (405(10492)):1865-1878 doi:10.1016/S0140-6736(25)00551-3.

    PMID: 40412861
  2. 2

    Insights into Pathogenesis of Trachoma.

    Toumasis P, Vrioni G, Tsinopoulos IT, et al.

    Microorganisms 2024; (12(8)) doi:10.3390/microorganisms12081544.

    PMID: 39203386
  3. 3

    Prevalence of Trachomatous Trichiasis in Ten Evaluation Units of Embu and Kitui Counties, Kenya.

    Ilako D, Barasa E, Gichangi M, et al.

    Ophthalmic epidemiology 2023; (30(6)):591-598 doi:10.1080/09286586.2021.1986549.

    PMID: 35037814
  4. 4

    Selecting behaviour change priorities for trachoma 'F' and 'E' interventions: A formative research study in Oromia, Ethiopia.

    Greenland K, White S, Sommers K, et al.

    PLoS neglected tropical diseases 2019; (13(10)):e0007784 doi:10.1371/journal.pntd.0007784.

    PMID: 31596851
  5. 5

    Gender differences in trachomatous scarring prevalence in a formerly trachoma hyperendemic district in Tanzania.

    Wolle MA, Muñoz BE, Mgboji G, et al.

    PLoS neglected tropical diseases 2024; (18(1)):e0011861 doi:10.1371/journal.pntd.0011861.

    PMID: 38277341
  6. 6

    Time trends and heterogeneity in the disease burden of trachoma, 1990-2019: a global analysis.

    He J, Chen A, Zou M, et al.

    The British journal of ophthalmology 2023; (107(3)):337-341 doi:10.1136/bjophthalmol-2021-319621.

    PMID: 34593412
  7. 7

    Progression of scarring trachoma in Tanzanian children: A four-year cohort study.

    Ramadhani AM, Derrick T, Macleod D, et al.

    PLoS neglected tropical diseases 2019; (13(8)):e0007638 doi:10.1371/journal.pntd.0007638.

    PMID: 31412025
  8. 8

    Trachoma.

    Solomon AW, Burton MJ, Gower EW, et al.

    Nature reviews. Disease primers 2022; (8(1)):32 doi:10.1038/s41572-022-00359-5.

    PMID: 35618795
  9. 9

    Pathogenesis of progressive scarring trachoma in Ethiopia and Tanzania and its implications for disease control: two cohort studies.

    Burton MJ, Rajak SN, Hu VH, et al.

    PLoS neglected tropical diseases 2015; (9(5)):e0003763 doi:10.1371/journal.pntd.0003763.

    PMID: 25970613
  10. 10

    Population-based prevalence survey of follicular trachoma and trachomatous trichiasis in the Casamance region of Senegal.

    Harding-Esch EM, Kadimpeul J, Sarr B, et al.

    BMC public health 2017; (18(1)):62 doi:10.1186/s12889-017-4605-0.

    PMID: 28747198
  11. 11

    Mass drug administration for trachoma: how long is not long enough?

    Jimenez V, Gelderblom HC, Mann Flueckiger R, et al.

    PLoS neglected tropical diseases 2015; (9(3)):e0003610 doi:10.1371/journal.pntd.0003610.

    PMID: 25799168
  12. 12

    Water, sanitation, and hygiene for control of trachoma in Ethiopia (WUHA): a two-arm, parallel-group, cluster-randomised trial.

    Aragie S, Wittberg DM, Tadesse W, et al.

    The Lancet. Global health 2022; (10(1)):e87-e95 doi:10.1016/S2214-109X(21)00409-5.

    PMID: 34919861
  13. 13

    Trachoma prevalence remains below threshold in five districts after stopping mass drug administration: results of five surveillance surveys within a hyperendemic setting in Amhara, Ethiopia.

    Nash SD, Stewart AEP, Astale T, et al.

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2018; (112(12)):538-545 doi:10.1093/trstmh/try096.

    PMID: 30265355

This page is for informational purposes only and does not constitute medical advice. An eye-care professional should evaluate inward-turning eyelashes, eye pain, discharge, or vision changes.